Variable | 2017–2019 N = 12,820 | 95% CI | 2020–2022 N = 29,523 | 95% CI |
---|---|---|---|---|
Age (years) | 66 (14) | 65.9, 66.4 | 66 (14) | 66, 67 |
Glycemia (mg/dl) | 97 (15) | 96, 97 | 98 (15) | 97, 98 |
Hb1Ac (%) | 6.17 (0.77) | 6.1, 6.2 | 6.23 (0.78) | 6.2, 6.3 |
Sex | ||||
F | 6830 (53%) | 52%, 54% | 16,078 (54%) | 54%, 55% |
M | 5978 (47%) | 46%, 48% | 13,435 (46%) | 45%, 46% |
Current or former smoking | ||||
NO | 4924 (73%) | 71%, 74% | 6496 (73%) | 72%, 74% |
YES | 1867 (27%) | 26%, 29% | 2388 (27%) | 26%, 28% |
BMI (kg/m2) | 26.6 (3.7) | 26, 27 | 26.5 (3.5) | 26, 27 |
Creatinine (mg/dl) | 0.89 (0.20) | 0.89, 0.90 | 0.90 (0.21) | 0.90, 0.91 |
ALT (mU/ml) | 20 (8) | 20, 21 | 20 (8) | 20.0, 20.4 |
AST (mU/ml) | 21 (6) | 20, 21 | 20 (6) | 20, 21 |
Cancer | ||||
NO | 8987 (70%) | 69%, 71% | 23,470 (79%) | 79%, 80% |
YES | 3833 (30%) | 29%, 31% | 6053 (21%) | 20%, 21% |
COPD | ||||
NO | 12,072 (94.2%) | 94%, 95% | 27,504 (93.2%) | 92.9%, 93.4% |
YES | 748 (5.8%) | 5.4%, 6.3% | 2019 (6.8%) | 6.6%, 7.1% |
Hypercholesterolemia | ||||
NO | 9812 (77%) | 76%, 77% | 23,224 (79%) | 78%, 79% |
YES | 3008 (23%) | 23%, 24% | 6299 (21%) | 21%, 22% |
Hypertriglyceridemia | ||||
NO | 12,433 (97%) | 96.7%, 97.3% | 28,976 (98.1%) | 98.0%, 98.3% |
YES | 387 (3%) | 2.7%, 3.3% | 547 (1.9%) | 1.7%, 2.0% |
COVID-19 | ||||
NO | 26,019 (88%) | 87.8%, 88.5% | ||
YES | 3504 (12%) | 11.5%, 12.2% |